ActiTrexx GmbH

Mitterfels, Bavaria, Germany

https://www.actitrexx.de/

Company profile

ActiTrexx GmbH company profile

ActiTrexx GmbH is a biotech start-up. They offer cellular therapy to prevent inflammatory reactions in conditions like GVHD, solid organ transplantation, and autoimmune diseases. Their ATREGA is a treatment option for transplanted patients, providing a substantial survival rate.

Business identity

Website: https://www.actitrexx.de/
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 00011-00050 employees
Revenue range: $1K+
Founded: 2019-01-01

Headquarters

Headquarters: Mitterfels, Bavaria, Germany
Postal code: 55131
Country code: DE
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 1
Total equity funding: $4.2M
Last funding: Series A / $4.2M / 2021-03-02
Last equity funding: Series A / $4.2M
Investors: 4
Lead investors: 1
Founders: 1
Articles: 1

Categories and groups

Biotechnology Biotechnology Science and Engineering

Founders and investors

Founders

Andrea Tüttenberg

Lead investors

LBBW VC

Investors

HTGF (High-Tech Gruenderfonds)Investitions- und Strukturbank Rheinland-PfalzLBBW VCMediVentures

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.